Clinical Trials

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Phase 3 Recruiting

258 enrolled

Breast Neoplasms

NCT07464769 2026-03-11

KompXX

358 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT06704659 2026-03-09

RAY-no-BAN

Breast Neoplasms, Recurrence

NCT07425379 2026-02-24

Prehabilitation in Breast Cancer Surgery

54 enrolled

Breast Neoplasms

NCT07416253 2026-02-18

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

68 enrolled

Breast Neoplasms

NCT07355569 2026-01-23

The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway

133,770 enrolled

Phase NA Enrolling by invitation

Attendance

NCT07357207 2026-01-23

VIT-BC

80 enrolled

Female Breast Cancer Patients

NCT06032390 2026-01-14

AIMS Norway

150,000 enrolled

Breast Neoplasms

NCT06967103 2026-01-08

QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer

238 enrolled

Breast Neoplasms

NCT07327021 2026-01-08

NOGA

54 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07301580 2025-12-24

Prehabilitation of Breast Cancer-Related Lymphedema

40 enrolled

Breast Cancer Lymphedema, Fatigue Syndrome, Chronic

NCT02698202 2025-12-19

Screening for Breast Cancer With Digital Breast Tomosynthesis

26,877 enrolled

Breast Neoplasms

NCT07274800 2025-12-10

UHF vs HF-EBC

Breast Neoplasms

NCT06817525 2025-12-05

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

64 enrolled

Triple Negative Breast Neoplasms

NCT07256964 2025-12-02

Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer

216 enrolled

Phase 1/2 Active not recruiting

Triple Negative Breast Neoplasms

NCT01992952 2025-11-26

FAKTION

149 enrolled

Estrogen Receptor Positive Breast Cancer

NCT07240584 2025-11-21

Prehab of BC

30 enrolled

Breast Neoplasms, Fatigue, Lymphedema

NCT07243418 2025-11-21

Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study

72 enrolled

Breast Neoplasms

NCT07198672 2025-09-30

Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag

45 enrolled

HER2-positive Breast Cancer

NCT06522971 2025-09-10

CancerBeat

55 enrolled

Breast Neoplasms

NCT07146009 2025-08-28

Targeted Nerve Surgery for the Prevention of Post-Mastectomy Pain Syndrome: A Randomized Trial

Breast Neoplasms

NCT01531036 2025-08-27

3D Breast Ultrasound Elastography in Patients Under Neoadjuvant Chemotherapy

33 enrolled

Malignant Breast Tumours

NCT03232541 2025-08-24

The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting

BreastGastrointestinalGenitourinary

198 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Vomiting, Colorectal Neoplasms

NCT05735795 2025-08-24

Feasibility of Carbon-Dye Marking of Axillary Lymph Nodes Before Neoadjuvant Chemotherapy in Patients With Breast Cancer

50 enrolled

Breast Neoplasms, Lymphatic Metastasis

NCT07136974 2025-08-22

Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.

280 enrolled

Breast Neoplasms

NCT07125950 2025-08-15

SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

Advanced Breast Cancer

NCT07101159 2025-08-03

Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

200 enrolled

Breast Neoplasms

NCT03755141 2025-07-22

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

Phase 2 Completed

109 enrolled 7 charts

Breast Neoplasms

NCT05394285 2025-07-17

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

Breast Neoplasms

NCT06243796 2025-07-11

Seroma Formation After Modified Radical Mastectomy With Flap Fixation Technique in Breast Cancer Patients

70 enrolled 8 charts

Breast Neoplasms

NCT04526561 2025-07-09

Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales

550 enrolled

Breast Neoplasms

NCT05722795 2025-07-09

I-CONIC

40 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07057427 2025-07-09

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Phase 3 Recruiting

812 enrolled

Breast Neoplasms

NCT03963427 2025-07-03

GoBreast

220 enrolled

Breast Cancer Female

NCT06195865 2025-07-03

GoBreast II

250 enrolled

Breast Neoplasms

NCT06751407 2025-07-03

Single-level and Two-level Serratus Posterior Superior Intercostal Plan Block (SPSIPB)

50 enrolled

Breast Neoplasms, Pain

NCT07047755 2025-07-02

Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

48 enrolled

Breast Neoplasms

NCT05663723 2025-06-26

Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer

186 enrolled

Breast Neoplasms, Peripheral Nervous System Diseases

NCT02824484 2025-06-25

A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURE

250 enrolled

BreastGastrointestinal

Breast Neoplasms, Neoplasms, Colorectal Neoplasms

NCT03941223 2025-06-25

Regional Anesthesia for Breast Surgery

Phase NA Withdrawn

Breast Neoplasms

NCT03992859 2025-06-25

Continuous Serrates Plane Block in Axillary Dissection

15 enrolled

Breast Neoplasms

NCT04461808 2025-06-25

MAITA

10,156 enrolled

Breast Neoplasms

NCT04862429 2025-06-25

BoCCE

200 enrolled

Breast Neoplasms, Calcinosis

NCT07037537 2025-06-25

Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat Transplantation

26 enrolled

Breast Neoplasms

NCT06629896 2025-06-24

CEM

2,200 enrolled

Phase 2 Active not recruiting

Breast Neoplasms, Disease

NCT06394661 2025-06-23

Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer

109 enrolled

Breast Neoplasms

NCT06860529 2025-06-23

Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer

357 enrolled

HR+/HER2- Breast Cancer

NCT06927180 2025-06-23

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

180 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT07023796 2025-06-17

Autologous Fat Infiltration Versus General Measures as Treatment in Radiodermatitis Induced for Radiotherapy in Breast Cancer Patients

22 enrolled